BCCCP: Pain Assessment and Analgesic Management

Question 1 of 10

1. Question

A critically ill patient in the ICU is experiencing severe pain. Consideration of social determinants of health is necessary in their pain management plan. Which factor is most likely to impact the effectiveness of pain management in this patient?

Limited access to prescribed pain medications due to cost constraints.
Patient’s genetic predisposition to higher pain tolerance.
ICU nurse’s experience with analgesic protocols.
Type of ventilator support used during ICU care.

Question 2 of 10

2. Question

Propose strategies to prevent ICU complications, including venous thromboembolism prophylaxis and stress ulcer prevention in patients receiving analgesics.

Early mobilization and use of mechanical prophylaxis (e.g., intermittent pneumatic compression devices) along with pharmacologic anticoagulation as appropriate.
Routine use of proton pump inhibitors for stress ulcer prevention in all ICU patients regardless of risk factors.
Administering analgesics without thromboprophylaxis or ulcer prevention measures as they do not increase risk.
Avoiding all anticoagulation in ICU patients due to bleeding risk.

Question 3 of 10

3. Question

Which validated pain scale is most appropriate for assessing pain intensity in non-verbal critically ill ICU patients?

Visual Analog Scale (VAS)
Behavioral Pain Scale (BPS)
Numeric Rating Scale (NRS)
McGill Pain Questionnaire

Question 4 of 10

4. Question

A 68-year-old man is admitted to the surgical ICU after emergency abdominal surgery for a perforated viscus. He is mechanically ventilated, sedated with propofol, and receives intermittent intravenous opioids. On ICU day 2, nurses note blood pressure elevations and agitation during routine turning and endotracheal suctioning. Which of the following statements about pain epidemiology and assessment in critically ill patients is most accurate?

Procedural pain occurs in fewer than 20% of ICU patients during routine interventions.
Background (resting) pain is uncommon in sedated and mechanically ventilated patients.
Over 50% of critically ill patients experience moderate to severe pain at rest and during procedures.
Pain assessment is unnecessary in sedated and mechanically ventilated patients because sedation eliminates discomfort.

Question 5 of 10

5. Question

Discuss the role of multidisciplinary goals of care discussions when considering escalations or de-escalations of invasive analgesic interventions in critical care or ICU settings.

Multidisciplinary goals of care discussions help align patient values and clinical realities before escalating invasive analgesic interventions.
Such discussions are only necessary after invasive analgesic interventions have been escalated.
Goals of care discussions are primarily the responsibility of the attending physician and need not involve other disciplines.
De-escalations of invasive analgesic interventions should occur without multidisciplinary input to expedite care.

Question 6 of 10

6. Question

Which of the following is the most essential component in monitoring analgesic efficacy and detecting drug-related toxicities in critically ill patients?

Regular pain assessment using validated scales such as the Critical-Care Pain Observation Tool (CPOT).
Monitoring sedation levels with tools like the Richmond Agitation-Sedation Scale (RASS).
Continuous hemodynamic monitoring including blood pressure, heart rate, and oxygen saturation.
Routine laboratory tests focusing on liver and renal function to detect drug toxicity.

Question 7 of 10

7. Question

Which of the following is the most reliable behavioral indicator for initial pain assessment in ICU patients who are unable to communicate effectively?

Patient self-reporting pain using verbal scale.
Observation of facial grimacing, restlessness, and moaning.
Monitoring vital signs such as elevated heart rate, blood pressure, and respiratory rate.
Relying solely on medical history without current patient assessment.

Question 8 of 10

8. Question

Analyze the impact of pre-existing chronic diseases such as diabetic neuropathy and opioid use disorder on the risk and presentation of pain in critically ill ICU patients.

Pre-existing diabetic neuropathy decreases the likelihood of pain perception in ICU patients.
Opioid use disorder increases tolerance and may alter the typical pain presentation in ICU patients.
Chronic diseases have no impact on pain risk or presentation in critically care settings.
Pre-existing neuropathies lead to an exaggerated pain response in all ICU patients.

Question 9 of 10

9. Question

Which of the following statements about analgesic dosing in patients with hepatic or renal impairment, including those receiving renal replacement therapy, is correct?

No adjustment is needed for opioids in patients with renal impairment.
Morphine should be avoided in advanced renal failure due to accumulation of active metabolites.
Fentanyl requires dose reduction in renal impairment but not in hepatic impairment.
NSAIDs are safe to use without adjustment during renal replacement therapy.

Question 10 of 10

10. Question

Select the most appropriate first-line analgesic agent for a critically ill ICU patient requiring pain management, considering current evidence-based guidelines. Which of the following options is recommended?

Intravenous morphine
Oral acetaminophen
Intramuscular ketorolac
Intravenous fentanyl

Quiz Summary

Information

Results